Poniard Pharmaceuticals, Inc. (PARD)
OTCMKTS · Delayed Price · Currency is USD
0.00001
0.00 (0.00%)
Apr 7, 2026, 9:30 AM EST
Poniard Pharmaceuticals Market Cap
Poniard Pharmaceuticals has a market cap or net worth of $15 as of April 8, 2026. Its market cap has decreased by -99.96% in one year.
Market Cap
15.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 11, 1988, Poniard Pharmaceuticals's market cap has decreased from 100.37M to 15.00, a decrease of -100.00%. That is a compound annual growth rate of -34.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 15.00 | 1,400.00% |
| Dec 30, 2021 | 1.00 | -100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synovics Pharmaceuticals | 36.00 |
| Neurobiological Technologies | 27.00 |
| Anthera Pharmaceuticals | 26.00 |
| Verde Science | 24.00 |
| Sienna Biopharmaceuticals | 23.00 |
| IMV Inc. | 15.00 |
| PhaseRx | 12.00 |
| ContraFect | 11.00 |